Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)*Andreas Wollenberg, Andrew Blauvelt, Emma Guttman‐Yassky et al.|British Journal of Dermatology|2020Cited by 590
Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase<scp>III</scp>trialsEric L. Simpson, Kristian Reich, Yuichiro Tsunemi et al.|British Journal of Dermatology|2020Cited by 377
A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized studyM Freeman, Peter Foley, C Vinciullo et al.|Journal of Dermatological Treatment|2003Cited by 286
Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trialDiana Rubel, Stephen Shumack, Lynda Spelman et al.|British Journal of Dermatology|2014Cited by 221
A prospective study of the use of cryosurgery for the treatment of actinic keratosesKeng‐Ee Thai, Peter Foley, Peter Fergin et al.|International Journal of Dermatology|2004Cited by 182